Regulation of stem cell signaling by nanoparticle-mediated intracellular protein delivery

Biomaterials

Volumn 32, Issue 12, 2011, Pages 3210-3219

  Shah, Dhiral A ^a   Kwon, Seok Joon ^a   Bale, Shyam S ^a   Banerjee, Akhilesh ^a   Dordick, Jonathan S ^a   Kane, Ravi S ^a  

^a Rensselaer Polytechnic Institute   (United States)

Author keywords

Catenin; FRATtide; GSK 3 ; Nanoparticle protein conjugates; Protein delivery; Wnt signaling

Indexed keywords

ACTIVE SITE; CELL FUNCTIONS; CELL SIGNALING; CHIMERIC PROTEINS; CYTOSOLS; FLUORESCENCE DETECTION; FRATTIDE; FUNCTIONAL PROTEINS; GLYCOGEN SYNTHASE KINASE-3; HUMAN EMBRYONIC KIDNEY CELLS; IN-VITRO; IN-VIVO; INTRACELLULAR DELIVERY; INTRACELLULAR PROTEIN DELIVERY; PROTEIN DELIVERY; PROTEIN KINASE; RAT NEURAL STEM CELLS; SIGNALING PATHWAYS; SIGNALING PROTEINS; SILICA NANOPARTICLES; TARGET GENES; WNT SIGNALING;

BIOMARKERS; ENZYME ACTIVITY; ENZYMES; MOLECULAR BIOLOGY; NANOPARTICLES; SILICA; STEM CELLS; TRANSCRIPTION;

SIGNALING;

BETA CATENIN; BIOLOGICAL MARKER; GLYCOGEN SYNTHASE KINASE 3BETA; HYBRID PROTEIN; MYC PROTEIN; NANOPARTICLE; SILICON; SILICON NANOPARTICLE; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; ENDOCYTOSIS; ENZYME ACTIVE SITE; ENZYME INHIBITION; FLUORESCENCE; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROPHOBICITY; IN VITRO STUDY; KIDNEY CELL CULTURE; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOGEN SYNTHASE KINASE 3; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INTRACELLULAR SPACE; NANOPARTICLES; NEURAL STEM CELLS; PEPTIDES; PROTEIN ENGINEERING; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SILICON DIOXIDE; TRANSFECTION;

RATTUS;

EID: 79951771258     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.11.077     Document Type: Article

References (67)

1. Katoh M. WNT signaling in stem cell biology and regenerative medicine. Curr Drug Targets 2008, 9(7):565-570.
2. Kitisin K., Saha T., Blake T., Golestaneh N., Deng M., Kim C., et al. Tgf-Beta signaling in development. Sci STKE 2007, 2007(399):cm1.
3. Li Y.Q. Master stem cell transcription factors and signaling regulation. Cell Reprogram 2010, 12(1):3-13.
4. Sato N., Meijer L., Skaltsounis L., Greengard P., Brivanlou A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 2004, 10(1):55-63.
5. Dravid G., Ye Z., Hammond H., Chen G., Pyle A., Donovan P., et al. Defining the role of Wnt/beta-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells. Stem Cells 2005, 23(10):1489-1501.
6. Willert K., Brown J.D., Danenberg E., Duncan A.W., Weissman I.L., Reya T., et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003, 423(6938):448-452.
7. Haegele L., Ingold B., Naumann H., Tabatabai G., Ledermann B., Brandner S. Wnt signalling inhibits neural differentiation of embryonic stem cells by controlling bone morphogenetic protein expression. Mol Cell Neurosci 2003, 24(3):696-708.
8. Cadigan K.M., Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 1997, 11(24):3286-3305.
9. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127(3):469-480.
10. Chenn A., Walsh C.A. Increased neuronal production, enlarged forebrains and cytoarchitectural distortions in beta-catenin overexpressing transgenic mice. Cereb Cortex 2003, 13(6):599-606.
11. Zechner D., Fujita Y., Hulsken J., Muller T., Walther I., Taketo M.M., et al. beta-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system. Dev Biol 2003, 258(2):406-418.
12. Frame S., Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J 2001, 359(Pt 1):1-16.
13. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004, 20:781-810.
14. Culbert A.A., Brown M.J., Frame S., Hagen T., Cross D.A., Bax B., et al. GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity. FEBS Lett 2001, 507(3):288-294.
15. Hawiger J. Cellular import of functional peptides to block intracellular signaling. Curr Opin Immunol 1997, 9(2):189-194.
16. Noda T., Kawamura R., Funabashi H., Mie M., Kobatake E. Transduction of neuroD2 protein induced neural cell differentiation. J Biotechnol 2006, 126(2):230-236.
17. Leader B., Baca Q.J., Golan D.E. Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov 2008, 7(1):21-39.
18. Panyam J., Labhasetwar V. Targeting intracellular targets. Curr Drug Deliv 2004, 1(3):235-247.
19. Zhang Y., Yu L.C. Microinjection as a tool of mechanical delivery. Curr Opin Biotechnol 2008, 19(5):506-510.
20. Wang K., Feramisco J.R., Ash J.F. Fluorescent localization of contractile-proteins in tissue-culture cells. Methods Enzymol 1982, 85:514-562.
21. Kochanek S., Schiedner G., Volpers C. High-capacity 'gutless' adenoviral vectors. Curr Opin Mol Ther 2001, 3(5):454-463.
22. Provoda C.J., Stier E.M., Lee K.D. Tumor cell killing enabled by listeriolysin O-liposome-mediated delivery of the protein toxin gelonin. J Biol Chem 2003, 278(37):35102-35108.
23. Zelphati O., Wang Y., Kitada S., Reed J.C., Felgner P.L., Corbeil J. Intracellular delivery of proteins with a new lipid-mediated delivery system. J Biol Chem 2001, 276(37):35103-35110.
24. Lindgren M., Hallbrink M., Prochiantz A., Langel U. Cell-penetrating peptides. Trends Pharmacol Sci 2000, 21(3):99-103.
25. Whittlesey K.J., Shea L.D. Nerve growth factor expression by PLG-mediated lipofection. Biomaterials 2006, 27(11):2477-2486.
26. Ehrengruber M.U., Hennou S., Bueler H., Naim H.Y., Deglon N., Lundstrom K. Gene transfer into neurons from hippocampal slices: comparison of recombinant semliki forest virus, adenovirus, adeno-associated virus, lentivirus, and measles virus. Mol Cell Neurosci 2001, 17(5):855-871.
27. Janson C.G., McPhee S.W., Leone P., Freese A., During M.J. Viral-based gene transfer to the mammalian CNS for functional genomic studies. Trends Neurosci 2001, 24(12):706-712.
28. Slack R.S., Miller F.D. Viral vectors for modulating gene expression in neurons. Curr Opin Neurobiol 1996, 6(5):576-583.
29. Maheshwari A., Mahato R.I., McGregor J., Han S.O., Samlowski W.E., Park J.S., et al. Soluble biodegradable polymer-based cytokine gene delivery for cancer treatment. Mol Ther 2000, 2(2):121-130.
30. Slowing, Trewyn B.G., Lin V.S.Y. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J Am Chem Soc 2007, 129(28):8845-8849.
31. Lim Y.T., Cho M.Y., Lee J.M., Chung S.J., Chung B.H. Simultaneous intracellular delivery of targeting antibodies and functional nanoparticles with engineered protein G system. Biomaterials 2009, 30(6):1197-1204.
32. Kam N.W.S., Jessop T.C., Wender P.A., Dai H.J. Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J Am Chem Soc 2004, 126(22):6850-6851.
33. Cartiera M.S., Johnson K.M., Rajendran V., Caplan M.J., Saltzman W.M. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials 2009, 30(14):2790-2798.
34. Panyam J., Zhou W.Z., Prabha S., Sahoo S.K., Labhasetwar V. Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 2002, 16(10):1217-1226.
35. Nel A.E., Madler L., Velegol D., Xia T., Hoek E.M., Somasundaran P., et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 2009, 8(7):543-557.
36. Hasadsri L., Kreuter J., Hattori H., Iwasaki T., George J.M. Functional protein delivery into neurons using polymeric nanoparticles. J Biol Chem 2009, 284(11):6972-6981.
37. Zhao X.J., Hilliard L.R., Mechery S.J., Wang Y.P., Bagwe R.P., Jin S.G., et al. A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles. Proc Natl Acad Sci USA 2004, 101(42):15027-15032.
38. Burns A.A., Vider J., Ow H., Herz E., Penate-Medina O., Baumgart M., et al. Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett 2009, 9(1):442-448.
39. Kumar R., Roy I., Ohulchanskky T.Y., Vathy L.A., Bergey E.J., Sajjad M., et al. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 2010, 4(2):699-708.
40. Bale S.S., Kwon S.J., Shah D.A., Banerjee A., Dordick J.S., Kane R.S. Nanoparticle-mediated cytoplasmic delivery of proteins to target cellular machinery. ACS Nano 2010, 4(3):1493-1500.
41. Hoover D.M., Lubkowski J. DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis. Nucleic Acids Res 2002, 30(10):e43.
42. Ferrer J.L., Jez J.M., Bowman M.E., Dixon R.A., Noel J.P. Structure of chalcone synthase and the molecular basis of plant polyketide biosynthesis. Nat Struct Biol 1999, 6(8):775-784.
43. Graham F.L., Smiley J., Russell W.C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977, 36(1):59-74.
44. Hart M., Concordet J.P., Lassot I., Albert I., del los Santos R., Durand H., et al. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 1999, 9(4):207-210.
45. Moon R.T., Bowerman B., Boutros M., Perrimon N. The promise and perils of Wnt signaling through beta-catenin. Science 2002, 296(5573):1644-1646.
46. Atcha F.A., Syed A., Wu B., Hoverter N.P., Yokoyama N.N., Ting J.H., et al. A unique DNA binding domain converts T-cell factors into strong Wnt effectors. Mol Cell Biol 2007, 27(23):8352-8363.
47. Barker N., Morin P.J., Clevers H. The yin-yang of TCF/beta-catenin signaling. Adv Cancer Res 2000, 77:1-24.
48. Novak A., Dedhar S. Signaling through beta-catenin and Lef/Tcf. Cell Mol Life Sci 1999, 56(5-6):523-537.
49. Doble B.W., Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003, 116(7):1175-1186.
50. Stambolic V., Ruel L., Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 1996, 6(12):1664-1668.
51. Li L., Yuan H., Weaver C.D., Mao J., Farr G.H., Sussman D.J., et al. Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. EMBO J 1999, 18(15):4233-4240.
52. Fraser E., Young N., Dajani R., Franca-Koh J., Ryves J., Williams R.S., et al. Identification of the Axin and Frat binding region of glycogen synthase kinase-3. J Biol Chem 2002, 277(3):2176-2185.
53. Thomas G.M., Frame S., Goedert M., Nathke I., Polakis P., Cohen P. A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin. FEBS Lett 1999, 458(2):247-251.
54. Bax B., Carter P.S., Lewis C., Guy A.R., Bridges A., Tanner R., et al. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure 2001, 9(12):1143-1152.
55. Kaidanovich-Beilin O., Eldar-Finkelman H. Peptides targeting protein kinases: strategies and implications. Physiology 2006, 21:411-418.
56. Shimomura O., Johnson F.H., Saiga Y. Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea. J Cell Comp Physiol 1962, 59:223-239.
57. Bergen J.M., Park I.K., Horner P.J., Pun S.H. Nonviral approaches for neuronal delivery of nucleic acids. Pharm Res 2008, 25(5):983-998.
58. Washbourne P., McAllister A.K. Techniques for gene transfer into neurons. Curr Opin Neurobiol 2002, 12(5):566-573.
59. Maurisse R., De Semir D., Emamekhoo H., Bedayat B., Abdolmohammadi A., Parsi H., et al. Comparative transfection of DNA into primary and transformed mammalian cells from different lineages. BMC Biotechnol 2010, 10:9.
60. Jia L.W., Miao C.L., Cao Y.J., Duan E.K. Effects of Wnt proteins on cell proliferation and apoptosis in HEK293 cells. Cell Biol Int 2008, 32(7):807-813.
61. Tseng A.S., Engel F.B., Keating M.T. The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes. Chem Biol 2006, 13(9):957-963.
62. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997, 16(13):3797-3804.
63. Coux O., Tanaka K., Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996, 65:801-847.
64. Eastman Q., Grosschedl R. Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol 1999, 11(2):233-240.
65. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., et al. Identification of c-MYC as a target of the APC pathway. Science 1998, 281(5382):1509-1512.
66. Barker N., Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 2007, 6(3). 249-249.
67. van Amerongen R., Nawijn M., Franca-Koh J., Zevenhoven J., van der Gulden H., Jonkers J., et al. Frat is dispensable for canonical Wnt signaling in mammals. Genes Dev 2005, 19(4):425-430.